Omar, J.M., Hamza, O.J., Matee, M.I., Simon, E.N., Kikwilu, E., Moshi, M.J., Mugusi, F., Mikx, F.H., Verweij, P.E. and van der Ven, A.J. (2006) Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health, 6, 12. doi: 10.1186/1472-6831-6-12. doi:10.1186/1472-6831-6-12

has been cited by the following article:

• TITLE: Maxillofacial sarcomas: a ugandan epidemiological survey

  AUTHORS: Kamulegeya Adriane

  KEYWORDS: Maxillofacial Sarcomas, Kaposi’s Sarcoma, Maxillofacial Tumors, Head and Neck Tumors

  JOURNAL NAME: Open Journal of Stomatology, Vol.1 No.2, July 1, 2011

  ABSTRACT: We reviewed the case notes of 203 patients who were treated for sarcomas of the oral and maxillofacial region over a period of 5 years. There were 98 male cases (mean age 31.4 ± 12.8 years) and 105 female cases (mean age 29.3 ± 10.4). Kaposi’s sarcoma accounted for 82.8% cases, and rhabdomyosarcoma 6.9% followed by osteosarcoma and chondrosarcoma at 2.5% each. Except for Kaposi’s sarcoma, surgery in combination with radiotherapy and/or chemothe- rapy was the main stay of treatment. Survival data was not available for most of our patients.